Ask Warren

ChoA Pharmaceutical

034940 · KOSDAQ · ₩034940 · 조아제약

₩1,704▼ ₩4 (0.23%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Other Market Notice (Market Capitalization Below ₩20B)기타시장안내 (시가총액 200억원 미달)Oct 7, 2026Open on DART
  • Trading halt주권매매거래정지해제 (액면병합 주권 변경상장)Aug 26, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Trading halt주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)Jul 31, 2026Open on DART
  • Results of Extraordinary Shareholders' Meeting임시주주총회결과Jul 6, 2026Open on DART
  • Exchange inquiry about a news report or price move조회공시요구(현저한시황변동)에대한답변(중요정보없음)Jun 24, 2026Open on DART
  • Exchange inquiry about a news report or price move조회공시요구(현저한시황변동)Jun 23, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Jun 19, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Jun 19, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정May 22, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의May 22, 2026Open on DART
  • Share Consolidation Decision주식병합결정May 22, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 23, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 13, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 13, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 25, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Feb 25, 2026Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 19, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Feb 19, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 10, 2025Open on DART
  • Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
  • Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
  • Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
  • Annual general meeting results정기주주총회결과Mar 24, 2025Open on DART
  • Audit report submitted감사보고서제출Mar 14, 2025Open on DART
  • Annual report (Dec 2024)사업보고서 (2024.12)Mar 14, 2025Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 28, 2025Open on DART
  • Notice of shareholders' meeting주주총회소집공고Feb 28, 2025Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 21, 2025Open on DART
  • Shareholders' meeting called주주총회소집결의Feb 21, 2025Open on DART
  • Resumption of Production (Voluntary Disclosure)생산재개(자율공시)Feb 3, 2025Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2024Open on DART
  • Production Halt생산중단Dec 10, 2024Open on DART
  • Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 14, 2024Open on DART
  • Half-year report (Jun 2024)반기보고서 (2024.06)Aug 14, 2024Open on DART
  • Change in Affiliated Companies (Voluntary Disclosure)계열회사변경(자율공시)May 17, 2024Open on DART
  • Quarterly report (Mar 2024)분기보고서 (2024.03)May 14, 2024Open on DART
  • Annual general meeting results정기주주총회결과Mar 25, 2024Open on DART
  • Audit report submitted감사보고서제출Mar 15, 2024Open on DART
  • Annual report (Dec 2023)사업보고서 (2023.12)Mar 15, 2024Open on DART
  • [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Feb 29, 2024Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 28, 2024Open on DART
  • Notice of shareholders' meeting주주총회소집공고Feb 28, 2024Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 23, 2024Open on DART
  • Shareholders' meeting called주주총회소집결의Feb 16, 2024Open on DART
  • 주주명부폐쇄기간또는기준일설정Dec 12, 2023Open on DART
  • Quarterly report (Sep 2023)분기보고서 (2023.09)Nov 14, 2023Open on DART
  • Half-year report (Jun 2023)반기보고서 (2023.06)Aug 14, 2023Open on DART
  • Quarterly report (Mar 2023)분기보고서 (2023.03)May 15, 2023Open on DART

Titles in Korean until English translations are added.

Also known as: ChoA Pharmaceutical / 조아제약 / 034940 / KRX:034940

Source: KRX statistical information